Literature DB >> 7793541

Time course of action and intubating conditions following vecuronium, rocuronium and mivacurium.

J M Wierda1, F D Hommes, H J Nap, L van den Broek.   

Abstract

The purpose of this study was to compare the time course of action and tracheal intubating conditions of vecuronium, rocuronium and mivacurium in anaesthetised patients. Anaesthesia consisted of thiopentone, fentanyl, N2O/O2 and isoflurane. After a 2 x ED90 dose the first attempt at tracheal intubation was made at 90 s. If required, maintenance doses of 0.5 x ED90 were administered. The intubating conditions after rocuronium were significantly better than those after vecuronium and mivacurium. The average onset times of rocuronium (172 s) and vecuronium (192 s) were significantly shorter than that of mivacurium (229 s). The clinical duration and recovery time were significantly shorter after mivacurium (13 and 6 min, respectively) than with vecuronium (33 and 14 min, respectively) and rocuronium (28 and 11 min, respectively). We conclude that rocuronium might be of advantage whenever the interval between the administration of the muscle relaxant and tracheal intubation must be short, whereas mivacurium may be of benefit if fast spontaneous recovery is required.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7793541     DOI: 10.1111/j.1365-2044.1995.tb05990.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  3 in total

Review 1.  Newer neuromuscular blocking agents: how do they compare with established agents?

Authors:  H J Sparr; T M Beaufort; T Fuchs-Buder
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Selective versus non-selective neural stimulation in the monitoring of muscular relaxation during general anesthesia.

Authors:  J Rodiera; R Calabuig; A Gual
Journal:  J Clin Monit Comput       Date:  1999-08       Impact factor: 2.502

3.  Effect of mivacurium 200 and 250 &mgr;g/kg in infants during isoflurane anesthesia: a randomized controlled trial [ISRCTN07742712].

Authors:  Alejandro A Nava-Ocampo; Ferel T Aguirre-Garay; Elvia Y Velázquez-Armenta; Diana Moyao-García
Journal:  BMC Anesthesiol       Date:  2001       Impact factor: 2.217

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.